REMAP-CAP Trial

All Done!

A bit more to do?    Log in


The latest from the Spiral blog . . .

Meet Jess, one of our Project Leads

2021-05-31


Ask her what a typical day or week looks like and Jess can’t help but laugh. 

 “Every day is different and every week throws up new challenges. I find myself to be very busy. The pressures of the pandemic are immense and with the trial being responsive, the build constantly needs to change...you hear of working in an agile environment but this really is as agile as it gets.” 


 
 

Follow us on Twitter

     
 

Like us on Facebook




 

REMAP-CAP

REMAP-CAP is a Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia. The primary aim of the study is to identify the effect of a range of interventions to improve all-cause mortality at 90 days.

About the software

Spinnaker is a tailored, web based, software and database solution for managing your multi-centre clinical study including the recording of patient data, recording and alerting of events, inventory management and reporting on data collected during the course of your study. Spinnaker is user friendly, adaptable and can be delivered quickly. You can read more on the Spinnaker website or contact Audrey on spinnaker@spiral.co.nz.

 

You can get to know us a little better through our blog and social media pages accessed via the logout screen of this trial.

This instance of REMAP-CAP hosted on our RELENTLESS server